Hospital
Pali Momi Medical Center
Pali Momi Medical Center was paid $49.28M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is 99283, emergency room visit (moderate) — 28% of everything it billed.
33Billing provider infoPALI MOMI MEDICAL CENTER
AIEA, HI 96701
AIEA, HI 96701
33aNPI1013961408assigned 05/20/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$49.28M
24GClaims715,392
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Hawaii
Rank by total paid#4 of 18
Median peer was paid$10.94M
This provider vs. median4.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 125,173 | $8.02M | |
| 2019 | 131,897 | $7.80M | |
| 2020 | 85,647 | $4.58M | |
| 2021 | 98,101 | $6.01M | |
| 2022 | 100,364 | $7.18M | |
| 2023 | 96,210 | $7.26M | |
| 2024incomplete | 78,000 | $8.43M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 28% | 31,321 | 28,525 | $14.04M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 23% | 15,841 | 13,942 | $11.20M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 20,752 | 18,874 | $10.31M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.5% | 7,643 | 7,232 | $2.70M |
| G0378 | Hospital observation service, per hour | 5.0% | 4,204 | 2,515 | $2.45M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.7% | 3,846 | 3,641 | $2.34M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.5% | 2,630 | 2,457 | $1.24M |
| L8699 | Prosthetic implant, not otherwise specified | 1.3% | 745 | 683 | $655K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 6,076 | 5,985 | $519K |
| A4649 | Surgical supply; miscellaneous | <1% | 55,548 | 41,245 | $372K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,146 | 1,071 | $360K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,051 | 1,971 | $290K |
241 more codes
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,189 | $233K |
| 77065 | Tomosynthesis, mammo | <1% | 2,615 | $215K |
| 77066 | Tomosynthesis, mammo | <1% | 1,971 | $214K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 1,222 | $184K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 2,158 | $175K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 327 | $141K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,445 | $124K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,413 | $95K |
| 76813 | <1% | 1,327 | $92K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 7,562 | $88K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,760 | $84K |
| 71250 | <1% | 809 | $78K | |
| 93976 | <1% | 756 | $64K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 86 | $60K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 4,344 | $57K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,054 | $56K |
| 76642 | <1% | 4,461 | $51K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12,964 | $50K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 628 | $47K |
| 36902 | <1% | 155 | $45K | |
| 72100 | <1% | 1,830 | $44K | |
| 76770 | <1% | 835 | $40K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,885 | $40K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 314 | $31K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,089 | $30K |
| 96367 | <1% | 2,989 | $29K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 2,373 | $29K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,025 | $28K |
| 36591 | <1% | 1,780 | $26K | |
| 76536 | <1% | 543 | $21K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 11,834 | $20K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 24,323 | $20K |
| 73130 | <1% | 1,499 | $18K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,037 | $18K |
| 73630 | <1% | 1,827 | $15K | |
| 77080 | <1% | 246 | $14K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 17 | $13K |
| 73610 | <1% | 1,571 | $13K | |
| 76801 | <1% | 177 | $12K | |
| 93017 | <1% | 767 | $11K | |
| 73030 | <1% | 1,609 | $11K | |
| 73560 | <1% | 966 | $10K | |
| 73110 | <1% | 735 | $10K | |
| 73562 | <1% | 1,043 | $9K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 199 | $9K |
| 74183 | <1% | 13 | $9K | |
| 76831 | <1% | 26 | $8K | |
| 86850 | <1% | 1,563 | $8K | |
| 36430 | <1% | 350 | $8K | |
| 73502 | <1% | 315 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 555 | $7K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 11,318 | $6K |
| 93971 | <1% | 272 | $5K | |
| 94060 | <1% | 135 | $5K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 24 | $4K |
| 94726 | <1% | 38 | $4K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 12 | $4K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 123 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,024 | $3K |
| 96415 | <1% | 277 | $3K | |
| J3490 | Unclassified drugs | <1% | 30,066 | $3K |
| 72141 | <1% | 12 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 7,164 | $2K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 60 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 228 | $2K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 12 | $2K |
| 73590 | <1% | 155 | $2K | |
| 73140 | <1% | 180 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,579 | $2K |
| 73564 | <1% | 26 | $2K | |
| 80305 | <1% | 2,669 | $2K | |
| 86920 | <1% | 271 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,042 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 10,050 | $1K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 536 | $1K |
| 87186 | <1% | 2,685 | $1K | |
| 80053 | Comprehensive metabolic panel | <1% | 25,017 | $1K |
| 74018 | <1% | 186 | $1K | |
| 10060 | <1% | 149 | $989.46 | |
| 72170 | <1% | 75 | $978.40 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 5,631 | $761.81 |
| 29125 | <1% | 27 | $740.03 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 36,525 | $708.75 |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 196 | $705.29 |
| 84132 | <1% | 2,334 | $704.79 | |
| 88341 | <1% | 58 | $664.00 | |
| 83880 | <1% | 4,023 | $630.34 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 11,026 | $584.33 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 8,506 | $502.08 |
| 84484 | <1% | 11,890 | $469.16 | |
| 96523 | <1% | 28 | $451.97 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,059 | $417.79 |
| A9270 | Non-covered item or service | <1% | 8,267 | $405.84 |
| 93308 | <1% | 12 | $316.65 | |
| 74022 | <1% | 432 | $276.69 | |
| 81025 | <1% | 7,461 | $267.81 | |
| 73080 | <1% | 15 | $258.44 | |
| 93246 | <1% | 16 | $238.37 | |
| 87040 | <1% | 3,009 | $237.85 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,070 | $180.91 |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 854 | $166.13 |
| 90715 | <1% | 1,573 | $162.55 | |
| 71101 | <1% | 70 | $161.76 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,117 | $159.13 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 2,771 | $152.93 |
| 83690 | <1% | 8,609 | $151.80 | |
| 76830 | Ultrasound, transvaginal | <1% | 3,110 | $127.59 |
| 83605 | <1% | 3,523 | $126.56 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,085 | $123.23 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 9,419 | $121.89 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,571 | $121.13 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,392 | $117.76 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,716 | $107.59 |
| 96376 | <1% | 3,634 | $107.53 | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | <1% | 516 | $102.13 |
| 84703 | <1% | 2,954 | $101.87 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 8,560 | $90.17 |
| A4648 | Tissue marker, implantable, any type, each | <1% | 12 | $89.91 |
| J1815 | Injection, insulin, per 5 units | <1% | 818 | $86.30 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 640 | $59.79 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,428 | $57.50 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 999 | $56.99 |
| 81003 | <1% | 6,652 | $55.43 | |
| 87077 | <1% | 3,364 | $52.56 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 24,531 | $50.12 |
| 81001 | <1% | 5,747 | $49.38 | |
| 83735 | <1% | 2,288 | $45.72 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,984 | $44.89 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 830 | $40.62 |
| 85379 | <1% | 449 | $39.56 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 679 | $38.04 |
| 85610 | <1% | 3,475 | $36.58 | |
| 82948 | <1% | 2,256 | $36.28 | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 698 | $34.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 2,848 | $32.17 |
| 73660 | <1% | 12 | $29.88 | |
| A4550 | Surgical trays | <1% | 5,911 | $28.80 |
| A4217 | Sterile water/saline, 500 ml | <1% | 1,390 | $28.41 |
| 85730 | <1% | 1,146 | $28.40 | |
| 81015 | <1% | 2,499 | $23.07 | |
| A4565 | Slings | <1% | 250 | $22.80 |
| 84702 | <1% | 83 | $20.80 | |
| 86901 | <1% | 2,123 | $20.67 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 562 | $20.28 |
| 73070 | <1% | 14 | $18.60 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 8,140 | $18.51 |
| 84145 | <1% | 37 | $17.77 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 2,682 | $16.13 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 445 | $13.62 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 1,042 | $10.68 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 1,524 | $9.97 |
| 87070 | <1% | 553 | $7.51 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 387 | $6.99 |
| A6257 | Transparent film, sterile, 16 sq. in. or less, each dressing | <1% | 4,944 | $5.88 |
| 82550 | <1% | 204 | $4.64 | |
| A4215 | Needle, sterile, any size, each | <1% | 15,818 | $4.31 |
| A4620 | Variable concentration mask | <1% | 3,567 | $4.17 |
| 86900 | <1% | 1,936 | $3.27 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 6,479 | $3.02 |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 4,031 | $3.01 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 20 | $2.30 |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | <1% | 343 | $2.07 |
| J2704 | Injection, propofol, 10 mg | <1% | 5,845 | $1.23 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 5,458 | $0.55 |
| A6403 | Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing | <1% | 1,349 | $0.44 |
| A6446 | Conforming bandage, non-elastic, knitted/woven, sterile, width greater than or equal to three inches and less than five inches, per yard | 0% | 370 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 220 | $0.00 |
| A4618 | Breathing circuits | 0% | 571 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 4,191 | $0.00 |
| 84100 | 0% | 336 | $0.00 | |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | 0% | 330 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 326 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 828 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 705 | $0.00 |
| A6258 | Transparent film, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing | 0% | 511 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 270 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 151 | $0.00 |
| 87075 | 0% | 72 | $0.00 | |
| J0688 | Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg | 0% | 52 | $0.00 |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 94 | $0.00 |
| 87660 | 0% | 160 | $0.00 | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 215 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 57 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 34 | $0.00 |
| J2720 | Injection, protamine sulfate, per 10 mg | 0% | 92 | $0.00 |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 0% | 65 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 26 | $0.00 |
| 82565 | 0% | 13 | $0.00 | |
| 94799 | 0% | 83 | $0.00 | |
| 77062 | 0% | 26 | $0.00 | |
| 96160 | 0% | 40 | $0.00 | |
| 58340 | 0% | 14 | $0.00 | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 0% | 13 | $0.00 |
| L1906 | Ankle foot orthosis, multiligamentous ankle support, prefabricated, off-the-shelf | 0% | 12 | $0.00 |
| 87634 | 0% | 27 | $0.00 | |
| Q9969 | Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose | 0% | 986 | $0.00 |
| J3471 | Injection, hyaluronidase, ovine, preservative free, per 1 usp unit (up to 999 usp units) | 0% | 117 | $0.00 |
| A7521 | Tracheostomy/laryngectomy tube, cuffed, polyvinylchloride (pvc), silicone or equal, each | 0% | 1,192 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 3,854 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 2,184 | $0.00 |
| 86140 | 0% | 165 | $0.00 | |
| 97162 | 0% | 63 | $0.00 | |
| A4570 | Splint | 0% | 453 | $0.00 |
| A9585 | Injection, gadobutrol, 0.1 ml | 0% | 1,544 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 200 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 525 | $0.00 |
| 87088 | 0% | 184 | $0.00 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 370 | $0.00 |
| B4083 | Stomach tube - levine type | 0% | 37 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 894 | $0.00 |
| A4467 | Belt, strap, sleeve, garment, or covering, any type | 0% | 1,124 | $0.00 |
| 87081 | 0% | 259 | $0.00 | |
| 88342 | 0% | 212 | $0.00 | |
| C1769 | Guide wire | 0% | 301 | $0.00 |
| C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away | 0% | 343 | $0.00 |
| 87205 | 0% | 39 | $0.00 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 1,203 | $0.00 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 72 | $0.00 |
| 88304 | 0% | 111 | $0.00 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 250 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 264 | $0.00 |
| 12002 | 0% | 14 | $0.00 | |
| 12001 | 0% | 64 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 204 | $0.00 |
| 87510 | 0% | 160 | $0.00 | |
| 87480 | 0% | 160 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 13 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 151 | $0.00 |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 46 | $0.00 |
| 85018 | 0% | 72 | $0.00 | |
| 80320 | 0% | 33 | $0.00 | |
| A4322 | Irrigation syringe, bulb or piston, each | 0% | 72 | $0.00 |
| 85651 | 0% | 78 | $0.00 | |
| A6448 | Light compression bandage, elastic, knitted/woven, width less than three inches, per yard | 0% | 14 | $0.00 |
| A6453 | Self-adherent bandage, elastic, non-knitted/non-woven, width less than three inches, per yard | 0% | 27 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 0% | 33 | $0.00 |
| 80329 | 0% | 14 | $0.00 | |
| 70486 | 0% | 16 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 25 | $0.00 |
| 80051 | 0% | 14 | $0.00 | |
| 88307 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOKABE, DAVID (CFO, SR. VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Kapiolani Medical Center for Women & Children | Honolulu, HI | $102.45M |
| Straub Clinic & Hospital | Honolulu, HI | $45.59M |
| Straub Clinic & Hospital | Honolulu, HI | $8.19M |
| Kapiolani Medical Specialists | Honolulu, HI | $5.15M |
| Kauai Medical Clinic | Lihue, HI | $4.98M |
| Kapiolani Medical Center for Women & Children | Honolulu, HI | $3.29M |
| Straub Clinic & Hospital | Honolulu, HI | $985K |
| Pali Momi Medical Center | Aiea, HI | $598K |
| Kapiolani Medical Center for Women & Children | Honolulu, HI | $154K |
| Straub Clinic & Hospital | Honolulu, HI | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.